Search Results - "Travagli, Alessia"
-
1
Microglia and Alzheimer's Disease
Published in International journal of molecular sciences (27-10-2022)“…There is a huge need for novel therapeutic and preventative approaches to Alzheimer's disease (AD) and neuroinflammation seems to be one of the most…”
Get full text
Journal Article -
2
Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer’s Disease
Published in International journal of molecular sciences (22-06-2022)“…Garlic, Allium sativum, has long been utilized for a number of medicinal purposes around the world, and its medical benefits have been well documented. The…”
Get full text
Journal Article -
3
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease
Published in Molecules (Basel, Switzerland) (21-04-2022)“…The A2A adenosine receptor is a protein belonging to a family of four GPCR adenosine receptors. It is involved in the regulation of several pathophysiological…”
Get full text
Journal Article -
4
Antioxidant and Antiinflammatory Effects of Epilobium parviflorum , Melilotus officinalis and Cardiospermum halicacabum Plant Extracts in Macrophage and Microglial Cells
Published in Cells (Basel, Switzerland) (08-10-2021)“…We investigated the phenolic content characterizing different plant extracts from , , and , their antioxidant, antiinflammatory effects, and their mechanism of…”
Get full text
Journal Article -
5
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?
Published in International journal of molecular sciences (02-05-2022)“…The A2A adenosine receptor, a member of the P1 purinergic receptor family, plays a crucial role in the pathophysiology of different neurodegenerative…”
Get full text
Journal Article -
6
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy
Published in Pharmaceutics (01-10-2023)“…The blood-brain barrier (BBB) is a biological barrier that protects the central nervous system (CNS) by ensuring an appropriate microenvironment. Brain…”
Get full text
Journal Article -
7
Pharmacology of Adenosine Receptors: Recent Advancements
Published in Biomolecules (Basel, Switzerland) (01-09-2023)“…Adenosine receptors (ARs) are widely acknowledged pharmacological targets yet are still underutilized in clinical practice. Their ubiquitous distribution in…”
Get full text
Journal Article -
8
Caffeine for Prevention of Alzheimer’s Disease: Is the A2A Adenosine Receptor Its Target?
Published in Biomolecules (Basel, Switzerland) (08-06-2023)“…Alzheimer’s disease (AD) is the most prevalent kind of dementia with roughly 135 million cases expected in the world by 2050. Unfortunately, current…”
Get full text
Journal Article -
9
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO
Published in Antioxidants (16-02-2023)“…Voghiera garlic is an Italian white garlic variety which obtained in 2010 the Protected Designation of Origin. It is widely used for culinary purposes or as an…”
Get full text
Journal Article -
10
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
Published in Frontiers in cell and developmental biology (04-05-2022)Get full text
Journal Article -
11
Caffeine for Prevention of Alzheimer’s Disease: Is the A[sub.2A] Adenosine Receptor Its Target?
Published in Biomolecules (Basel, Switzerland) (01-06-2023)“…Alzheimer’s disease (AD) is the most prevalent kind of dementia with roughly 135 million cases expected in the world by 2050. Unfortunately, current…”
Get full text
Journal Article -
12
A 2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?
Published in International journal of molecular sciences (02-05-2022)“…The A2A adenosine receptor, a member of the P1 purinergic receptor family, plays a crucial role in the pathophysiology of different neurodegenerative…”
Get full text
Journal Article -
13
Caffeine for Prevention of Alzheimer's Disease: Is the A 2A Adenosine Receptor Its Target?
Published in Biomolecules (Basel, Switzerland) (08-06-2023)“…Alzheimer's disease (AD) is the most prevalent kind of dementia with roughly 135 million cases expected in the world by 2050. Unfortunately, current…”
Get full text
Journal Article -
14
Pathophysiological Role and Medicinal Chemistry of A 2A Adenosine Receptor Antagonists in Alzheimer's Disease
Published in Molecules (Basel, Switzerland) (21-04-2022)“…The A adenosine receptor is a protein belonging to a family of four GPCR adenosine receptors. It is involved in the regulation of several pathophysiological…”
Get full text
Journal Article